Clinical trials
Phase 3 HIV Infections trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
305 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 13 |
| 2001 | 10 |
| 2002 | 12 |
| 2003 | 5 |
| 2004 | 13 |
| 2005 | 13 |
| 2006 | 6 |
| 2007 | 10 |
| 2008 | 7 |
| 2009 | 9 |
| 2010 | 7 |
| 2011 | 6 |
| 2012 | 8 |
| 2013 | 6 |
| 2014 | 2 |
| 2015 | 5 |
| 2016 | 4 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 5 |
| 2020 | 4 |
| 2022 | 1 |
| 2023 | 5 |
| 2024 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 266 |
| Unknown status | 13 |
| Terminated | 12 |
| Active, not recruiting | 7 |
| Withdrawn | 3 |
| Recruiting | 2 |
| Suspended | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 77 |
| ViiV Healthcare | 29 |
| Gilead Sciences | 21 |
| Bristol-Myers Squibb | 19 |
| Glaxo Wellcome | 17 |
| Hoffmann-La Roche | 15 |
| GlaxoSmithKline | 9 |
| Boehringer Ingelheim | 8 |
| Merck Sharp & Dohme LLC | 6 |
| Pfizer | 6 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| HIV Infections | 305 |
| Acquired Immunodeficiency Syndrome | 105 |
| AIDS-Related Complex | 29 |
| AIDS-Related Opportunistic Infections | 22 |
| Pneumonia, Pneumocystis | 18 |
| Infections | 13 |
| Cytomegalovirus Infections | 7 |
| Sarcoma, Kaposi | 7 |
| Cytomegalovirus Retinitis | 6 |
| Pregnancy Complications, Infectious | 6 |
Trials
Showing 1 to 25 of 305. Each trial links to its page on Pharma Observatory.
205 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.